Details for Patent: 6,150,398
✉ Email this page to a colleague
Summary for Patent: 6,150,398
Title: | Methods for the treatment of cancer |
Abstract: | A pharmaceutical composition comprising an effective cancerous cell growth inhibiting amount of paclitaxel, or a paclitaxel derivative, and an effective cancerous cell growth inhibiting amount of an active agent which inhibits cancerous cell growth by exerting an effect on mammalian cell cycle during G.sub.1 or S-phase of the cell division cycle to inhibit said cancerous cell growth and methods of using same. |
Inventor(s): | Vande Woude; George F. (Berryville, VA), Schulz; Nicholas (Pittsburgh, PA), Zhou; Renping (Frederick, MD), Daar; Ira (Frederick, MD), Oskarsson; Marianne (Gaitherburg, MD) |
Assignee: | The United States of America as represented by the Department of Health and Human Services (Washington, DC) |
Application Number: | 08/618,863 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 6,150,398
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,150,398
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2005692 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 9219765 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |